International Quality Medicines – Generic & Biosimilar

General information

In an effort to improve Vietnamese patients’ access to quality medicines, the International Quality Medicines (IQMED) – Generic & Biosimilar, former International Quality Generics (IQGx) Sector Committee was established in October 2016 under EuroCham's Healthcare Forum, raising the total number of Sector Committees under EuroCham to 16 and promising to become an active partner for key healthcare stakeholders.
With the aim of pooling viewpoints and superior practices towards providing solutions for an affordable, high-quality and sustainable supply source for branded generic drugs in Vietnam, IQMED – Generic & Biosimilar Sector Committee has created a platform where issues and solutions can be discussed among like-minded business professionals in the industry.

The IQMED – Generics & Biosimilar Sector Committee also contributes to the annual EuroCham Whitebook, focusing on specific recommendations to the Vietnamese Government towards an ever-improving business environment for the healthcare industry and helping patients get better access to affordable and high-quality pharmaceutical products in the country.

The Sector Committee is currently chaired by Ms. Magdalena Krakowiak. The IQMED – Generic & Biosimilar Sector Committee is in the process of extending its members, as well as discussing priority topics for the group’s future internal work, activities and projects.

The activities of the EuroCham IQMED – Generics & Biosimilar Sector Committee, guided by a strong commitment to their common mission, focus on a baseline of key interests: delivering an affordable, high quality, sustainable supply of trusted branded generic medicines and services to Vietnamese people; policy advocacy and collaboration with key healthcare stakeholders such as the Government, providers and payers in Vietnam, towards building efficient legal frameworks and implementation platforms.

Key interests and Position paper

EuroCham Whitebook 2020 - International Quality Medicines (IQMED) – Generic & Biosimilar Sector chapter
EuroCham Whitebook 2019 - International Quality Medicines (IQMED) – Generic & Biosimilar Sector chapter


  • The Representative Office of  Abbott Laboratories S.A. in Vietnam-EPD
  • The Representative Office of Actavis International Ltd in Vietnam
  • The Representative Office of Adamed Pharma S.A in Vietnam
  • The Representative Office of Aguettant Asia Pacific Pte. Ltd in Vietnam
  • The Representative Office of B.Braun Vietnam Company Limited
  • The Representative Office of Baxter Healthcare (Asia) Pte Ltd in Vietnam
  • The Representative Office of Egis Pharmaceuticals PLC in Vietnam 
  • The Representative Office of Mapbiopharma S.L (Spain) in HCMC
  • The Representative Office of Novartis (Singapore) Pte Ltd in Ho Chi Minh City
  • The Representative Office of GSK in Ho Chi Minh city
  • The Representative Office of JSC Grindeks in Vietnam


Mrs. Magdalena Krakowiak
Adamed Pharma

Mrs. Ho Thi Thanh Van
Sandoz Vietnam

Mr. Aleksanders Parfjonovs
JSC Grindeks

Legislations and Other publications

Corporate Platinum Partners

Our Partners/Supporters

Corporate Gold Partners

Corporate Silver Partners

Premium Service Partners